mRNA-0217 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mRNA-0217 vaccine, covering 2025-04-01 to 2025-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors [EARLY_Phase 1]